STOCK TITAN

RenaissanceRe EVP sells 9,623 shares in plan trade

RenaissanceRe’s EVP and Chief Portfolio Officer reported pre-planned open-market sales totaling 9,623 common shares under a Rule 10b5-1 plan.

(Very High)
(Negative)
Form Type
4

Rhea-AI Filing Summary

RENAISSANCERE HOLDINGS LTD (RNR) executive Curtis Ross, EVP and Chief Portfolio Officer, reported selling a total of 9,623 shares of common stock on September 3, 2026. The sales consisted of 4,623 shares at $335.00 and 5,000 shares at $340.00, all effected pursuant to a Rule 10b5-1 trading plan adopted on May 18, 2026.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

Insider Curtis Ross
Role EVP,Chief Portfolio Officer
Sold 9,623 shs ($3.25M)
Type Security Shares Price Value
Sale Common Stock F1 4,623 $335.00 $1.55M
Sale Common Stock F1 5,000 $340.00 $1.70M
Holdings After Transaction: Common Stock — 155,991 shares (Direct)
Footnotes (1)
  1. F1. All sales were effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 18, 2026.
Shares sold (first transaction) 4,623 shares Common stock sale on September 3, 2026 at $335.00 per share
Price per share (first transaction) $335.00 Open-market or private sale of 4,623 common shares on September 3, 2026
Shares sold (second transaction) 5,000 shares Common stock sale on September 3, 2026 at $340.00 per share
Price per share (second transaction) $340.00 Open-market or private sale of 5,000 common shares on September 3, 2026
Total shares sold 9,623 shares Aggregate of both reported common stock sales on September 3, 2026
Rule 10b5-1 plan regulatory
"All sales were effected pursuant to a Rule 10b5-1 plan adopted"
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.
open market or private transaction market
"Sale in open market or private transaction"

FAQ

What insider transactions did RNR report for Curtis Ross on this Form 4?

The Form 4 reports that Curtis Ross, EVP and Chief Portfolio Officer, sold a total of 9,623 shares of RenaissanceRe common stock on September 3, 2026 in two open‑market transactions.

How many RNR shares did Curtis Ross sell in each transaction?

Curtis Ross sold 4,623 shares at $335.00 per share and 5,000 shares at $340.00 per share of RenaissanceRe common stock, all on September 3, 2026.

Were the RNR insider sales by Curtis Ross under a Rule 10b5-1 plan?

Yes. The filing states that all sales were effected pursuant to a Rule 10b5-1 plan adopted by Curtis Ross on May 18, 2026, and the Rule 10b5-1 plan checkbox is marked as affirmed.

What is the total number of RNR shares sold by Curtis Ross in this Form 4?

Across both reported transactions, Curtis Ross sold 9,623 shares of RenaissanceRe common stock, based on sales of 4,623 shares and 5,000 shares on September 3, 2026.

What role does Curtis Ross hold at RNR in this Form 4?

Curtis Ross is identified as an officer of RenaissanceRe Holdings Ltd., serving as EVP, Chief Portfolio Officer, in connection with the reported insider transactions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Curtis Ross

(Last)(First)(Middle)
RENAISSANCE HOUSE
12 CROW LANE

(Street)
PEMBROKEHM 19

(City)(State)(Zip)

BERMUDA

(Country)
2. Issuer Name and Ticker or Trading Symbol
RENAISSANCERE HOLDINGS LTD [ RNR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
EVP,Chief Portfolio Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/03/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock09/03/2026S(1)4,623D$335160,991D
Common Stock09/03/2026S(1)5,000D$340155,991D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. All sales were effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 18, 2026.
Remarks:
/s/ Molly E. Gardner, Attorney-in-Fact09/03/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)